PembrolizumabWorsening of chronic inflammatory demyelinating polyneuropathy weakness: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2018年 / 1706卷 / 1期

关键词：

D O I：

10.1007/s40278-018-47738-4

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：409 / 409

相关论文

共 50 条

[21] A Case of Chronic Inflammatory Demyelinating Polyneuropathy: A Reminder
Saylisaoy, Suzan
Atlanoglu, Sahinde
Ozbabalik, Demet
Adapinar, Baki
TURKISH JOURNAL OF NEUROLOGY, 2011, 17 (01) : 62 - 63
[22] AdalimumabChronic inflammatory demyelinating polyneuropathy: case report
Reactions Weekly, 2017, 1634 (1) : 16 - 16
[23] InfliximabChronic inflammatory demyelinating polyneuropathy: case report
Reactions Weekly, 2023, 1948 (1) : 239 - 239
[24] TozinameranChronic inflammatory demyelinating polyneuropathy: case report
Reactions Weekly, 2022, 1923 (1) : 465 - 465
[25] TacrolimusChronic inflammatory demyelinating polyneuropathy?: case report
Reactions Weekly, 1999, 765 (1) : 12 - 12
[26] RanibizumabAcute inflammatory demyelinating polyneuropathy: case report
Reactions Weekly, 2023, 1955 (1) : 327 - 327
[27] TacrolimusChronic inflammatory demyelinating polyneuropathy: case report
Reactions Weekly, 2021, 1856 (1) : 368 - 368
[28] InfliximabChronic inflammatory demyelinating polyneuropathy: case report
Reactions Weekly, 2020, 1821 (1) : 139 - 139
[29] TozinameranChronic inflammatory demyelinating polyneuropathy: case report
Reactions Weekly, 2022, 1917 (1) : 544 - 544
[30] TozinameranAcute inflammatory demyelinating polyneuropathy: case report
Reactions Weekly, 2022, 1923 (1) : 458 - 458

← 1 2 3 4 5 →